SNY

Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge

07/16 01:00 am

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

07/16 01:00 am

Adagene announces up to $25 million strategic investment from Sanofi

07/01 07:00 am

Viscosupplementation Market Size to Reach USD 11.37 Billion by 2032 Owing to Rising Geriatric Population and Growing Osteoarthritis Incidence – SNS Insider

06/29 02:01 pm

United States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption

06/25 05:56 am

Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation

06/25 01:00 am

Communiqué de presse : Le riliprubart est désigné comme médicament orphelin aux États-Unis pour le rejet induit par les anticorps dans la transplantation d’organes solides

06/25 01:00 am

Flu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges

06/20 10:59 am

FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder

06/20 10:47 am

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

06/15 11:22 am

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute 1ere étude respiratoire de ph4 en comparaison directe …

06/15 11:22 am

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial

06/15 11:21 am

Influenza Market Analysis Report 2025 with Forecast to 2029: Government Support and Funding for Novel Therapies and Diagnosis Fueling Developments

06/10 05:48 am

Sanofi: Information concerning the total number of voting rights and shares - May 2025

06/09 05:10 pm

Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color

06/07 06:30 pm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY

06/06 12:43 pm

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

06/06 07:00 am

Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals

06/02 08:35 am

Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout

06/02 08:12 am

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi

06/02 07:00 am

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

05/30 08:30 am

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

05/30 01:00 am

Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials

05/30 01:00 am

Communiqué de presse : L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO

05/30 01:00 am

Penicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F

05/29 10:58 am

Drug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities

05/29 05:42 am

Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children

05/27 12:29 pm

Prurigo Nodularis Market - Global and Regional Analysis and Forecasts 2025-2035 | Advancements in Biologic Therapies Revolutionize Prurigo Nodularis Treatment

05/26 10:53 am

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

05/24 08:06 am

8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - Pipeline Innovations Expected to Add $1.8 Billion in Bronchiectasis Market Sales

05/23 04:49 am

Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

05/22 07:21 am

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

05/21 07:30 pm

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

05/21 07:30 pm

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline

05/21 07:15 pm

Communiqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie

05/21 07:15 pm

Aplastic Anemia Global Clinical Trials Review, 2025 | Explore Trends and Enrollment Data in Aplastic Anemia Clinical Trials

05/20 06:59 am

Recludix Pharma Presents Data Demonstrating Potent Efficacy and High Selectivity of a STAT6 Inhibitor in Preclinical Asthma Model

05/19 08:00 am

Questex’s Fierce Healthcare Announces 2025 Fierce DEI Award Finalists

05/14 02:00 pm

Sanofi: A megelőzésbe való befektetés Európa egészségének és versenyképességének alapja

05/07 03:14 am

Sanofi: Investițiile în prevenție susțin sănătatea și competitivitatea Europei

05/07 03:14 am

Sanofi: Information concerning the total number of voting rights and shares - March 2025

05/02 12:00 pm

Sanofi: Informations relatives au nombre de droits de vote et d'actions – Mars 2025

05/02 12:00 pm

AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma

05/02 10:18 am

Communiqué de presse : Sanofi et CD&R finalisent la cession d’Opella et créent un leader mondial de la santé grand public

04/30 07:00 am

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader

04/30 07:00 am

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

04/29 07:00 am

Communiqué de presse :

04/29 07:00 am

Communiqué de presse : Quand chaque seconde compte : Sanofi, McLaren Racing et United Autosports s'unissent pour sensibiliser à la méningite aux 24 Heures du Mans

04/29 07:00 am

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

04/29 07:00 am

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

04/28 04:00 pm